Page 3 - Clinical Trials

Bharat Biotech-Brazil row: Covaxin nod under controlled conditions

The agency said the suspension - which put the EUA application on ice - was due to missing data from the vaccine's clinical trials

Covaxin 77.8% effective against symptomatic Covid-19: Bharat Biotech

The company claimed Covaxin is the first to report promising efficacy against asymptomatic infections based on qPCR testing that will help in reducing disease transmission

Recruitment for Covaxin trial in 6-12 age group to start from June 15

The recruitment for the clinical trial of the country's first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS here from Tuesday. This will be followed by the clinical trial of children in the age-group of 2-6 years. The enrolment of children volunteers aged 12-18 years at the All India Institute of Medical Sciences (AIIMS) has been completed and they have been given the first dose of Covaxin. "The recruitment process for the clinical trial of Covaxin among children in the age group of 6-12 years will begin from Tuesday," Dr Sanjay Rai, Professor at the Centre for Community Medicine at the AIIMS, told PTI. The Drugs Controller General of India (DCGI) had granted permission for conducting the phase 2/3 clinical trial of Bharat Biotech's Covaxin among children aged two to 18 years on May 12. The trial is to be conducted in three parts -- 175 volunteers each in the groups aged 12-18, 6-12 and 2-6 years. In the tr

Novavax Covid-19 shot shows 90% efficacy, Serum Institute starts production

On track to make 100 mn doses per month by Q3 of 2021

CSIR begins clinical trials for Niclosamide drug as Covid-19 treatment

Council of Scientific and Industrial Research (CSIR) along and Laxai Life Sciences Pvt. Ltd. on Sunday initiated Phase-II clinical trial for anti-helminitic drug Niclosamide for treatment of Covid-19.

Zydus Cadila seeks regulator nod for clinical trials on Covid-19 therapy

Company says product helps treating mild coronavirus patients and reduces hospitalisation.

Phase-3 clinical trials for 2-DG may continue till Aug: Registry data

The clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals and involving 220 patients may continue till August.

Bharat Biotech's Covaxin approved for phase 2/3 trials on children

India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin Covid-19 vaccine in the age group of 2 to 18 years

Experts recommend Covaxin for phase 2/3 trials on those aged 2-18 year

Bharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said

Bharat Biotech's Krishna Ella wants maximum price for its vaccine

Says the company would like to recover the costs incurred in clinical trials, and other things and reinvest the money into R&D to be ready for future pandemics

Clinical trials on India's first mRNA Covid-19 vaccine to begin soon

Gennova's Covid vaccine candidate HGCO19 would remain stable at 2 to 8 degree Celsius temperature

Covid-19 vaccine: Bharat Biotech's Covaxin goes off clinical trial mode

Expert panel recommends emergency use authorisation

Russian, Chinese hacking groups target pharma companies for Covid-19 data

Singapore-based cyber intelligent firm Cyfirma says 15 active hacking campaigns are underway; US, UK and Japan among a slew of other nations also on cybercriminals' target list

All data pertaining to Covid vaccine trials should be made public: PMSF

Progressive Medicos and Scientists Forum said the Clinical Trial (PMSF) Phase 3 data should be evaluated in a transparent manner as and when available for India for both vaccines

Covid-19 vaccine: Bharat Biotech completes recruitment for phase 3 trials

More than 5,000 people have been given both shots of the vaccine; efficacy data around March

India Coronavirus Dispatch: Nod to Covaxin raises many eyebrows

Other vaccines being developed in India, dangerous conspiracy theories, private hospitals keen on jumping in-news relevant to India's fight against Covid-19

Zydus gets DCGI nod for conducting phase-3 clinical trials of ZyCoV-D

Company to initiate trials with around 30,000 volunteers

CDSCO panel to reconvene on Jan 1 to consider vaccine's emergency use

An expert panel in the Central Drugs Standard Control Organisation that met on Wednesday to consider emergency use authorisation applications will reconvene on Jan 1 to deliberate on the matter.

Biotech's Covaxin shows good results in clinical trials: Research paper

Covaxin, being developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is now undergoing phase-3 trials

Fortune or foresight? AstraZeneca, Oxford stories clash on Covid-19 vaccine

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose